Here Monday’s Wall Street: Analyst Calls on NVIDIA, Alphabet
A wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
Transform your credit card points into charitable contributions. Discover how to donate your rewards and support meaningful causes in your community.
17,798 articlesA wave of fresh analyst upgrades and price-target bumps hits NVIDIA, Alphabet, and other big names as markets start t...
Microsoft Copilot AI released a multi-path forecast for Bitcoin, placing today’s price at a key inflection point. The...
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
A storied dividend king trades at a discount as Wall Street shifts away. Here’s why patient investors are doubling do...
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
Two AI-era stock stories headline this guide: Palantir as an undervalued growth play and Sandisk as a growth leader w...
As investors hunt for catalysts in 2026, the idea of a blockbuster stock split from Booking Holdings stands out. This...
U.S. regulators have begun a CIP-based compliance clock for stablecoin issuers, tying direct customer onboarding to f...
As Xometry heads into 2025 earnings, investors seek clarity on growth, margins, and execution. This guide provides ac...
AI is accelerating the pace at which startups reach unicorn status, with policy shifts and market volatility adding c...
Investors grapple with AI-driven disruption as markets remain volatile in early 2026. Experts outline disciplined ste...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...